Literature DB >> 16612209

Insights from recent positron emission tomographic studies of drug abuse and dependence.

Linda Chang1, William Haning.   

Abstract

PURPOSE OF REVIEW: Recent positron emission tomographic studies demonstrate a variety of abnormalities in the brains of addicted individuals. This review aims to discuss and highlight these findings. RECENT
FINDINGS: The recent findings are as follows: (a) the reward response to an addictive substance is associated with increased dopamine release in the striatum. (b) Activation of the orbitofrontal region is involved in the reinforcing properties of a drug. (c) Behavioral, cognitive and affective abnormalities are associated with alterations in specific brain networks and regions (e.g., prefrontal cortices) in drug abusers. (d) Personality traits may play a role in the susceptibility to addiction and the brain's responses to drugs. (e) Sex-differences exist for cue-induced craving. (f) Several studies have confirmed decreased D2 receptors in drug users, which is associated with increased salience to drug cues. (g) Serotonergic transporters are decreased in the current users of 3,4-methylene-deoxy-methamphetamine but found normal in the past users of 3,4-methylene-deoxy-methamphetamine.
SUMMARY: Abnormalities in the dopaminergic, opioid, and serotonergic systems in drug abusers are seen in positron emission tomography scans. Decreased D2 receptor densities in drug users, whether premorbid or the consequence of substance misuse, imply a source of the susceptibility to relapse of this population. Insights from these studies could lead to better treatment approaches targeting specific neurotransmitter systems.

Entities:  

Mesh:

Year:  2006        PMID: 16612209     DOI: 10.1097/01.yco.0000218594.46431.2f

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  6 in total

1.  Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.

Authors:  M A De Luca; M Solinas; Z Bimpisidis; S R Goldberg; G Di Chiara
Journal:  Neuropharmacology       Date:  2011-11-02       Impact factor: 5.250

2.  Impaired time perception and motor timing in stimulant-dependent subjects.

Authors:  Marc Wittmann; David S Leland; Jan Churan; Martin P Paulus
Journal:  Drug Alcohol Depend       Date:  2007-04-16       Impact factor: 4.492

3.  Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.

Authors:  Katherine J Smith; Tracy R Butler; Mark A Prendergast
Journal:  Neurosci Lett       Date:  2010-06-30       Impact factor: 3.046

4.  Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.

Authors:  Katherine J Smith; Tracy R Butler; Rachel L Self; Brittany B Braden; Mark A Prendergast
Journal:  Brain Res       Date:  2007-10-18       Impact factor: 3.252

Review 5.  Treatment for amphetamine psychosis.

Authors:  Steven J Shoptaw; Uyen Kao; Walter Ling
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

6.  Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.

Authors:  Maria Antonietta De Luca; Valentina Valentini; Zisis Bimpisidis; Fabio Cacciapaglia; Pierluigi Caboni; Gaetano Di Chiara
Journal:  Front Psychiatry       Date:  2014-10-17       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.